Sudarshan Pharma Industries Limited

BSE:543828 Stock Report

Market Cap: ₹10.0b

Sudarshan Pharma Industries Management

Management criteria checks 2/4

Sudarshan Pharma Industries' CEO is Hemal Mehta, appointed in Nov 2018, has a tenure of 6.08 years. total yearly compensation is ₹4.80M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 28.51% of the company’s shares, worth ₹2.85B. The average tenure of the management team and the board of directors is 6.1 years and 2.4 years respectively.

Key information

Hemal Mehta

Chief executive officer

₹4.8m

Total compensation

CEO salary percentage100.0%
CEO tenure6.1yrs
CEO ownership28.5%
Management average tenure6.1yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Hemal Mehta's remuneration changed compared to Sudarshan Pharma Industries's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹125m

Jun 30 2024n/an/a

₹120m

Mar 31 2024₹5m₹5m

₹115m

Sep 30 2023n/an/a

₹83m

Jun 30 2023n/an/a

₹72m

Mar 31 2023₹5m₹5m

₹70m

Mar 31 2022₹4m₹4m

₹52m

Mar 31 2021₹1m₹1m

₹27m

Mar 31 2020₹500k₹500k

₹13m

Compensation vs Market: Hemal's total compensation ($USD56.21K) is above average for companies of similar size in the Indian market ($USD42.28K).

Compensation vs Earnings: Hemal's compensation has been consistent with company performance over the past year.

CEO

Hemal Mehta (47 yo)

6.1yrs

Tenure

₹4,800,000

Compensation

Mr. Hemal Vasantrai Mehta serves as a Managing Director at Sudarshan Pharma Industries Limited since November 8, 2018 and its Executive Director since January 16, 2015. He serves as the Chairman at Sudarsh...

Leadership Team

NamePositionTenureCompensationOwnership
Hemal Mehta
Chairman & MD6.1yrs₹4.80m28.51%
₹ 2.8b
Sachin Mehta
CFO, Joint MD & Director6.3yrs₹4.80m28.88%
₹ 2.9b
Nirav Shah
Company Secretary & Compliance Officerless than a yearno datano data
Shrishti Mayekar
Head of Sales & Marketingno datano datano data
Indraraj Neogi
Head of Sales & Marketing of Pharma Division7.3yrsno datano data
Bhavesh Kankia
Supply Chain Purchase Headno datano datano data
Geeta Asare
Supply Chain Logistics Headno datano datano data
Shrinivas Patil
Export Headno datano datano data
Vinay Singh
Independent Head of Pharma business in Manufacturing & Strategic Marketingno datano datano data
Nilesh Thakkar
Vice President - Head Business Development Internationalless than a yearno datano data

6.1yrs

Average Tenure

44yo

Average Age

Experienced Management: 543828's management team is seasoned and experienced (6.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hemal Mehta
Chairman & MD9.9yrs₹4.80m28.51%
₹ 2.8b
Sachin Mehta
CFO, Joint MD & Director16.4yrs₹4.80m28.88%
₹ 2.9b
Rushabh Patil
Independent Director1.4yrs₹60.00kno data
Umesh Luthra
Independent Director2.8yrsno datano data
Jaya Singhania
Independent Director2yrs₹99.00kno data
Anil Ghogare
Non-Executive Director1.1yrsno datano data

2.4yrs

Average Tenure

44yo

Average Age

Experienced Board: 543828's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 22:02
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sudarshan Pharma Industries Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution